(NASDAQ:SMLR), NEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the “Class Period”). A class […]

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SMLR GlobeNewswire August 30, 2025 NEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class

NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / WHY: New York, N.Y., August 30, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of KinderCare Learning Companies, Inc. (NYSE:KLC) pursuant and/or traceable to the registration statement issued in connection with KinderCare’s October 2024 initial public

(NASDAQ:CAPR), NEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the “Class Period”), of the important September 15, 2025 lead plaintiff deadline. SO WHAT: If

CAPR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPR GlobeNewswire August 30, 2025 NEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR)

(NYSE:KLC),(NYSE:CTO),(NasdaqGM:PUBM),(NASDAQ:CHTR), NEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of KinderCare Learning Companies, Inc. (NYSE:KLC), CTO Realty Growth, Inc. (NYSE:CTO), PubMatic, Inc. (NASDAQ:PUBM), and Charter Communications, Inc. (NASDAQ:CHTR). Stockholders have until

Bragar Eagel & Squire, P.C. Reminds Investors of KinderCare, CTO Realty, PubMatic, and Charter Communications that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm GlobeNewswire August 30, 2025 NEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class

(NASDAQ:AMRN), — 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or Very High-Risk Patients Based on REDUCE-IT — DUBLIN and BRIDGEWATER, N.J., Aug. 30, 2025 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today highlighted three sub-analyses from the REDUCE-IT(R) trial describing the impact of VASCEPA(R)/VAZKEPA(R)

(NYSE:NVO),(NasdaqGM:ALT),(NYSE:SLQT),(NASDAQ:SPPI), NEW YORK, Aug. 30, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (NYSE:NVO), Altimmune, Inc. (NASDAQ:ALT), SelectQuote, Inc. (NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Stockholders have until the deadlines below

New REDUCE-IT(R) Analyses Presented at ESC 2025 Include Data Showing VASCEPA(R)/VAZKEPA(R) (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups GlobeNewswire August 30, 2025 — 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or Very